TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29037222

Group type: EXPERIMENTAL
Intervention: ICT-based centralized home monitoring system
Number of subjects: 114

Group type: COMPARATOR
Intervention: Ambulatory follow-up
Number of subjects: 114
Study: 26378828

Group type: EXPERIMENTAL
Intervention: YMCA adaptation of the Diabetes Prevention Program (YDPP)
Number of subjects: 509

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 509
Study: 25231496

Group type: EXPERIMENTAL
Intervention: Community intervention: symptom awareness campaign tailored for rural Australians.
Number of subjects: 1350

Group type: EXPERIMENTAL
Intervention: GP intervention: resource card with symptom risk assessment charts and local referral pathways.
Number of subjects: 1350
Study: 22714063

Group type: EXPERIMENTAL
Intervention: Vaginal administration of Cyclogest (400 mg, twice daily for up to 8 weeks)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Rectal administration of Cyclogest (400 mg, twice daily for up to 8 weeks)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Both vaginal and rectal administration of Cyclogest
Number of subjects: 147
Study: 20845015

Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Ropivacaine
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 17

Group type: COMPARATOR
Intervention: Bupivacaine, Ropivacaine, Levobupivacaine
Number of subjects: 17
Study: 17674518

Group type: EXPERIMENTAL
Intervention: Selenium enriched food supplement based on spirulina
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 80
Study: 15598451

Group type: EXPERIMENTAL
Intervention: MRI examination of the injured knee during leg-press against resistance
Number of subjects: 31

Group type: COMPARATOR
Intervention: MRI examination of the loaded knees
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: ACL injury
Number of subjects: 31
Study: 12360176

Group type: EXPERIMENTAL
Intervention: Direct stent implantation (DS+)
Number of subjects: 338

Group type: COMPARATOR
Intervention: Standard stent implantation with balloon predilatation (DS-)
Number of subjects: 338
Study: 10710009

Group type: EXPERIMENTAL
Intervention: Ferrum H (5x2ml intramuscular injections)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Normal saline (Placebo Group)
Number of subjects: 15
Study: 7749807

Group type: EXPERIMENTAL
Intervention: Gemfibrozil (10 to 12 weeks)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 2264362

Group type: EXPERIMENTAL
Intervention: Parenteral immunization with 'Influmun' from SSW Dresden, GDR
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Oral immunization with an inactivated influenza vaccine using enteric-coated capsules
Number of subjects: 360

Group type: COMPARATOR
Intervention: Non-immunized group
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Immunized groups (both parenteral and oral)
Number of subjects: 360
Study: 7041579

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (Trental 400 mg coated tablets)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nylidrin HCl (3 mg)
Number of subjects: 60
Study: 30529451

Group type: EXPERIMENTAL
Intervention: ACET Program (computerized decision support tool)
Number of subjects: 0
Study: 28745656

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.1% and diclofenac 0.1% (n=20 eyes, Group I)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bromfenac 0.09% (n=20 eyes, Group II)
Number of subjects: 40
Study: 25397788

Group type: EXPERIMENTAL
Intervention: Optimized Prolate Ablation (OPA)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Optical Path Difference Custom Aspheric Treatment (OPDCAT)
Number of subjects: 53
Study: 23820974

Group type: EXPERIMENTAL
Intervention: Active 890-nm light therapy combined with hot-pack therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo 890-nm light therapy combined with hot-pack therapy
Number of subjects: 60
Study: 18040527

Group type: EXPERIMENTAL
Intervention: Colchicine therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Colchicine and vitamin E therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 14986189

Group type: EXPERIMENTAL
Intervention: Endurance training (Square-Wave Endurance Exercise Test) for 6 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (daily activities)
Number of subjects: 15
Study: 10606908

Group type: EXPERIMENTAL
Intervention: Topical 10 per cent phenylephrine
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo gels
Number of subjects: 36
Study: 9352981

Group type: EXPERIMENTAL
Intervention: Alteplase
Number of subjects: 146

Group type: COMPARATOR
Intervention: Streptokinase
Number of subjects: 146

Group type: COMPARATOR
Intervention: Combination of streptokinase and alteplase
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Irrespective of treatment
Number of subjects: 146
Study: 10124199

Group type: EXPERIMENTAL
Intervention: Rural residents with a history of depressive symptoms
Number of subjects: 200

Group type: COMPARATOR
Intervention: Urban residents with a history of depressive symptoms
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Negative labeling
Number of subjects: 200
Study: 3739811

Group type: EXPERIMENTAL
Intervention: Nicotine delivered in research cigarettes
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Nicotine delivered in tobacco snuff
Number of subjects: 25
Study: 31510943

Group type: EXPERIMENTAL
Intervention: Birth at health facility
Number of subjects: 226

Group type: COMPARATOR
Intervention: Birth at home
Number of subjects: 226
Study: 28835513

Group type: EXPERIMENTAL
Intervention: pembrolizumab (200 mg IV every 3 weeks)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: pembrolizumab (2 mg/kg IV every 3 weeks)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: pembrolizumab (10 mg/kg IV every 3 weeks)
Number of subjects: 2

Group type: COMPARATOR
Intervention: docetaxel (75 mg/m2 every 3 weeks)
Number of subjects: 2
Study: 25979373

Group type: EXPERIMENTAL
Intervention: Additional laboratory screening for STIs before IUC insertion
Number of subjects: 672

Group type: COMPARATOR
Intervention: No additional screening for STIs before IUC insertion
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: Both groups (additional laboratory screening and no additional screening)
Number of subjects: 672
Study: 24092379

Group type: EXPERIMENTAL
Intervention: Hand‐assisted retroperitoneoscopic donor nephrectomy (HARP)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Standard laparoscopic donor nephrectomy (LDN)
Number of subjects: 190
Study: 21295842

Group type: EXPERIMENTAL
Intervention: 1,000 IU hCG
Number of subjects: 719

Group type: COMPARATOR
Intervention: 1 mL saline (control)
Number of subjects: 719
Study: 19413790

Group type: EXPERIMENTAL
Intervention: MRC+I (motivated referral condition with monetary incentives)
Number of subjects: 281

Group type: COMPARATOR
Intervention: MRC (motivated referral condition)
Number of subjects: 281

Group type: COMPARATOR
Intervention: SRC (standard referral condition)
Number of subjects: 281
Study: 16890770

Group type: EXPERIMENTAL
Intervention: Environmental tobacco smoke (ETS)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Clean air
Number of subjects: 19
Study: 15610829

Group type: EXPERIMENTAL
Intervention: Structured group counseling program (cognitive-behavioral relapse prevention approach)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Naltrexone treatment (50 mg daily)
Number of subjects: 97
Study: 11726444

Group type: EXPERIMENTAL
Intervention: Neostigmine 10 microg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (no neostigmine)
Number of subjects: 36
Study: 9425673

Group type: EXPERIMENTAL
Intervention: Older adults (65 years old)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Younger adults (20 years old)
Number of subjects: 2
Study: 8503715

Group type: EXPERIMENTAL
Intervention: Group A (n = 8) reheated between 10 and 25 minutes
Number of subjects: 17

Group type: COMPARATOR
Intervention: Group B (n = 9) reheated between 26 and 50 minutes
Number of subjects: 17
Study: 3324563

Group type: EXPERIMENTAL
Intervention: Clenbuterol tablets (40 micrograms twice daily, later 20 micrograms twice daily)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Fenoterol perlongettes
Number of subjects: 61
Study: 29135651

Group type: EXPERIMENTAL
Intervention: Tenofovir film (40 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Tenofovir gel (1% 40 mg)
Number of subjects: 10
Study: 27263068

Group type: EXPERIMENTAL
Intervention: Refeeding
Number of subjects: 15
Study: 25027267

Group type: EXPERIMENTAL
Intervention: Home-based educational intervention with an average of ten prenatal home visits from a trained mentor providing information on healthy prenatal behaviours and social support.
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Home-based educational intervention
Number of subjects: 233

Group type: COMPARATOR
Intervention: Control group received care as usual including standard antenatal classes.
Number of subjects: 233
Study: 22682082

Group type: EXPERIMENTAL
Intervention: Milk protein sip feeding (Whey protein meal)
Number of subjects: 0
Study: 19627427

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 18176233

Group type: EXPERIMENTAL
Intervention: Juvéderm Ultra Plus
Number of subjects: 87

Group type: COMPARATOR
Intervention: Zyplast collagen
Number of subjects: 87
Study: 15695979

Group type: EXPERIMENTAL
Intervention: Cooperative group trials for Stage IB 2 disease treated with radiation therapy
Number of subjects: 2075

Group type: EXPERIMENTAL
Intervention: Cooperative group trials
Number of subjects: 2075

Group type: COMPARATOR
Intervention: SEER database
Number of subjects: 2075
Study: 12471626

Group type: EXPERIMENTAL
Intervention: HPV DNA testing
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Anti-VLPs testing for HPV types 16, 18, 31, 33, and 58
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Age-standardized prevalence of HPV DNA
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Age-standardized prevalence of anti-VLPs
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Risk factors for HPV DNA and anti-VLPs
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: HPV DNA prevalence among women whose husbands were thought to have extra-marital affairs
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: HPV DNA prevalence among women who had undergone vasectomy
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Anti-VLPs prevalence among virgins
Number of subjects: 863
Study: 10629347

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200

Group type: COMPARATOR
Intervention: Glycine 0.5 g/day
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Glycine 1.0 g/day
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Glycine 2.0 g/day
Number of subjects: 200
Study: 8853584

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 613
Study: 1353607

Group type: COMPARATOR
Intervention: 500 mg per day of didanosine
Number of subjects: 913

Group type: COMPARATOR
Intervention: 750 mg per day of didanosine
Number of subjects: 913

Group type: EXPERIMENTAL
Intervention: 600 mg per day of zidovudine
Number of subjects: 913
Study: 6375804

Group type: EXPERIMENTAL
Intervention: 400 mg metronidazole three times daily for seven days
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: 2000 mg metronidazole as a single dose
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: 2000 mg metronidazole on days 1 and 2
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: 2000 mg metronidazole on days 1 and 3
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: 1200 mg metronidazole once daily for five days
Number of subjects: 429
Study: 31587102

Group type: EXPERIMENTAL
Intervention: Allopurinol 50 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Allopurinol 100 mg
Number of subjects: 22
Study: 30290598

Group type: EXPERIMENTAL
Intervention: Scalp acupuncture combined with cognitive training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine treatment and cognitive rehabilitation training
Number of subjects: 60
Study: 26965760

Group type: EXPERIMENTAL
Intervention: Higher salt intake group (>=10.0 g/day, n=362)
Number of subjects: 793

Group type: COMPARATOR
Intervention: Lower salt intake group (<10.0 g/day, n=431)
Number of subjects: 793
Study: 23980239

Group type: EXPERIMENTAL
Intervention: Caffeine mouth-rinse (35 mg of anhydrous caffeine in 25 ml for 10 s, administered eight times)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo mouth-rinse (25 ml for 10 s, administered eight times)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Caffeine mouth-rinse
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo mouth-rinse
Number of subjects: 10
Study: 22755506

Group type: EXPERIMENTAL
Intervention: Dutasteride treatment (duration not specified)
Number of subjects: 142
Study: 20210592

Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation (FES) therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 30
Study: 17011248

Group type: EXPERIMENTAL
Intervention: Glibenclamide 3.5 mg per dose
Number of subjects: 0
Study: 15823823

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg/day for 28 days
Number of subjects: 61

Group type: COMPARATOR
Intervention: Sequential estrogen-progestogen therapy (0.625 mg CEE for 25 days + 5 mg MPA on days 16-25)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Sequential estrogen-progestogen therapy
Number of subjects: 61
Study: 11991622

Group type: EXPERIMENTAL
Intervention: rebamipide (300 mg daily for 12 months)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 86
Study: 9850405

Group type: EXPERIMENTAL
Intervention: Oral halofantrine 8 mg/kg body weight every 6 h for 3 doses
Number of subjects: 42
Study: 8720766

Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 16
Study: 2809856

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 300 mg daily for 1 week, followed by 3.4 g eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for 4 weeks
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 3.4 g daily of EPA and DHA for 4 weeks, followed by ASA 300 mg daily for 1 week
Number of subjects: 22
Study: 1124175

Group type: EXPERIMENTAL
Intervention: Copper T 300
Number of subjects: 776

Group type: EXPERIMENTAL
Intervention: Dalkon Shield
Number of subjects: 776

Group type: EXPERIMENTAL
Intervention: Shell Loop
Number of subjects: 776
Study: 31343517

Group type: EXPERIMENTAL
Intervention: Fermented soy extract (30 g powdered supplement in 16 fl. ounces of water)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (same quantities of organic cocoa powder and water)
Number of subjects: 25
Study: 31278924

Group type: EXPERIMENTAL
Intervention: High-load intradialytic group (HLG, 8-10 repetitions)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Moderate-load intradialytic group (MLG, 16-18 repetitions)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (CG, stretching exercise)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both RT protocols (HLG and MLG)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High-load intradialytic group (HLG)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Moderate-load intradialytic group (MLG)
Number of subjects: 80
Study: 28817535

Group type: EXPERIMENTAL
Intervention: Prasugrel (60 mg loaded before PCI)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Clopidogrel (dual antiplatelet therapy)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Genotyping
Number of subjects: 94

Group type: COMPARATOR
Intervention: PFT
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control
Number of subjects: 94
Study: 25294250

Group type: EXPERIMENTAL
Intervention: Oritavancin (single intravenous 1200-mg dose)
Number of subjects: 1005

Group type: COMPARATOR
Intervention: Vancomycin (7-10 days of twice-daily treatment)
Number of subjects: 1005
Study: 22986420

Group type: EXPERIMENTAL
Intervention: 125 mg methylprednisolone (MP)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 48
Study: 20400244

Group type: EXPERIMENTAL
Intervention: Consensus guideline and atlas for anorectal cancers (Group A)
Number of subjects: 14

Group type: COMPARATOR
Intervention: No consensus guideline and atlas (Group B)
Number of subjects: 14
Study: 19566621

Group type: EXPERIMENTAL
Intervention: Behavioral parent-only intervention (n = 34)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Behavioral family-based intervention (n = 33)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Waitlist control condition (n = 26)
Number of subjects: 93
Study: 17050227

Group type: EXPERIMENTAL
Intervention: QVAR alone
Number of subjects: 44
Study: 15036395

Group type: EXPERIMENTAL
Intervention: Eccentric training (21-session 7-week program consisting of 5x6 eccentric muscle actions at 60‐100% of concentric three maximal repetitions)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Eccentric training (specifically at -30 degrees s(-1))
Number of subjects: 14
Study: 11082781

Group type: EXPERIMENTAL
Intervention: Novel PCR-mediated amplification protocol for degraded ancient DNA
Number of subjects: 4
Study: 8650814

Group type: EXPERIMENTAL
Intervention: Intranasal insulin therapy
Number of subjects: 31

Group type: COMPARATOR
Intervention: Subcutaneous fast‐acting insulin
Number of subjects: 31
Study: 1401533

Group type: EXPERIMENTAL
Intervention: Binaural condition with broadband noise (interaural phase difference of 0 and pi) masking a 500-Hz probe tone (No pi S pi)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Monaural condition with spectral power density of the masker 15 dB lower below or above the edge frequency (N pi oS pi)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Comparison of binaural and monaural conditions
Number of subjects: 4
Study: 4009770

Group type: EXPERIMENTAL
Intervention: Short-board technique
Number of subjects: 97

Group type: COMPARATOR
Intervention: Philadelphia collar
Number of subjects: 97

Group type: COMPARATOR
Intervention: Hare extrication collar
Number of subjects: 97

Group type: COMPARATOR
Intervention: Rigid plastic collar
Number of subjects: 97

Group type: COMPARATOR
Intervention: Philadelphia collar + short board
Number of subjects: 97

Group type: COMPARATOR
Intervention: Hare extrication collar + short board
Number of subjects: 97

Group type: COMPARATOR
Intervention: Rigid plastic collar + short board
Number of subjects: 97

Group type: COMPARATOR
Intervention: Short board used alone
Number of subjects: 97
Study: 3303937

Group type: EXPERIMENTAL
Intervention: Ritodrine tocolysis (intravenous initially, then oral if successful)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 79
Study: 29288561

Group type: EXPERIMENTAL
Intervention: Flurbiprofen oral spray and ibuprofen
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ibuprofen alone
Number of subjects: 100
Study: 29141694

Group type: EXPERIMENTAL
Intervention: ICU diary written by staff and family, given to the patient at ICU discharge or to the family in case of death.
Number of subjects: 700

Group type: COMPARATOR
Intervention: Control group without any ICU diary.
Number of subjects: 700
Study: 26387408

Group type: EXPERIMENTAL
Intervention: Traditional Thai Massage (TTM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (bed rest)
Number of subjects: 30
Study: 24693632

Group type: COMPARATOR
Intervention: NaF (2% sodium fluoride solution)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Diode Laser (DL)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: NaF-DL combination
Number of subjects: 24

Group type: COMPARATOR
Intervention: HEMA-G (Gluma desensitizer)
Number of subjects: 24
Study: 21813162

Group type: EXPERIMENTAL
Intervention: warfarin plus 75‐100 mg aspirin
Number of subjects: 1496

Group type: COMPARATOR
Intervention: warfarin only
Number of subjects: 1496
Study: 18714623

Group type: EXPERIMENTAL
Intervention: 0 cmH2O PEEP applied for 20 minutes, followed by 5 cmH2O PEEP for 20 minutes, then 10 cmH2O PEEP for 20 minutes (Group A)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 5 cmH2O PEEP applied and maintained for one hour (Group B)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PEEP levels set in the opposite order to that of group A (Group C)
Number of subjects: 30
Study: 16556753

Group type: EXPERIMENTAL
Intervention: Computer-assisted navigation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard instrumentation
Number of subjects: 60
Study: 12687839

Group type: COMPARATOR
Intervention: 8‐mm tip catheter
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: irrigated tip catheter
Number of subjects: 60
Study: 10781115

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Piritramide
Number of subjects: 80
Study: 8814512

Group type: EXPERIMENTAL
Intervention: Three 20 km and three 40 km time trials (TT) on an air-braked ergometry system (Kingcycle) (n = 6)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Three 40 km laboratory TT and two 40 km road TT competitions (n = 8)
Number of subjects: 10
Study: 1428729

Group type: EXPERIMENTAL
Intervention: Doxorubicin (DXR) incorporated into polyisohexylcyanoacrylate nanoparticles at 75 mg/m2
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Doxorubicin (DXR) incorporated into polyisohexylcyanoacrylate nanoparticles
Number of subjects: 21
Study: 3830930

Group type: EXPERIMENTAL
Intervention: L-tryptophan (1 g with 10 g of CHO, three times a day, 30 min before meals)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: L-tryptophan
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (baseline)
Number of subjects: 8
Study: 31490194

Group type: EXPERIMENTAL
Intervention: Abdominal binder
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no abdominal binder)
Number of subjects: 0
Study: 29696666

Group type: EXPERIMENTAL
Intervention: High-dose NS-0200 (1.1 g leucine/0.5 g metformin/1.0 mg sildenafil)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Low-dose NS-0200 (1.1 g leucine/0.5 g metformin/0.5 mg sildenafil)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 27305855

Group type: EXPERIMENTAL
Intervention: AccuNavi‐A system
Number of subjects: 56

Group type: COMPARATOR
Intervention: Strker system
Number of subjects: 56